NCT03140670 2023-09-28Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based TherapyAbramson Cancer Center at Penn MedicinePhase 2 Terminated46 enrolled 16 charts